All In MedTech

Device Trial Radar · NCT04787926

DuraLock-C Catheter Lock Solution

A Multicenter, Open-Label Study to Evaluate the Safety and Performance of DuraLock-C 4.0%, 30.0%, and 46.7% for the Maintenance of Central Venous Catheter Patency in Adult Hemodialysis Subjects Treated in Clinic

Last checked: Nov 20, 2026Latest source record: Jan 10, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

17

Actual

Start

Sep 23, 2021

Primary completion

Jun 1, 2023

Study completion Jun 1, 2023

Sponsor

Lead sponsor
Medical Components, Inc dba MedCompNot on our public-company list
Sponsor type
Industry
Collaborators
Syneos Health; Veeva Systems
First posted
Mar 9, 2021

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the safety and performance of DuraLock-C 4.0%, 30.0%, and 46.7% for the maintenance of central venous catheter (CVC) patency in adult hemodialysis (HD) patients

Conditions

  • Catheter-Related Infections
  • Citrate Adverse Reaction

Interventions

  • Locking SolutionDevice

    The total duration of the study treatment period will be 90 calendar days, from Visit 1 Pre-Instillation to the last study-related assessment. Two to 3 instillations (1 per lumen per visit) of DuraLock-C 4.0%, 30.0%, or 46.7% (equivalent to the catheter manufacturer's prescribed priming volume) will be instilled 1 to 3 days apart (with a HD schedule of 3 to 4 times per week); each instillation of CLS will remain in the CVC for approximately 24 to 72 hours ± 12 hours, based on their practice preferences. EOS will take place at the patient's next scheduled dialysis session.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary Catheter PatencyTime frame: 90 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Clinique HEMERA Pays de Caux, 14 .A avenue Foch

    Yvetot, France

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.